Elevance Health shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and cut its price target from $646 to $530.
Portfolio Pulse from Benzinga Newsdesk
Elevance Health shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and cut its price target from $646 to $530.
July 18, 2024 | 2:33 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Elevance Health shares are trading lower following a downgrade by B of A Securities from Buy to Neutral, with a price target cut from $646 to $530.
The downgrade from Buy to Neutral by a major financial institution like B of A Securities, along with a significant reduction in the price target, is likely to negatively impact investor sentiment and lead to a short-term decline in Elevance Health's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100